Why is Transgene Biotek falling/rising?

As of 01-October, Transgene Biotek Ltd's stock price is currently at 4.18, reflecting an increase of 0.22 or 5.56%. The stock has shown a trend reversal, gaining after two consecutive days of decline. It has outperformed its sector by 4.85% today, and the delivery volume has increased by 4.41% compared to the 5-day average, indicating rising investor participation. However, despite this positive movement, the stock's year-to-date performance remains significantly negative at -38.80%, and its one-year return is down by 45.00%. The stock is currently trading above its 5-day and 20-day moving averages but below its longer-term averages, which suggests mixed momentum.
In the broader market context, the Sensex has experienced a decline of 0.90% over the past week, while Transgene Biotek has gained 2.45% in the same period, indicating that the stock is performing well relative to the benchmark. Despite the recent uptick, the stock's long-term performance is concerning, with a three-year return of +32.70% compared to the Sensex's +41.02%. This suggests that while there may be short-term positive sentiment around Transgene Biotek, the overall market conditions and the stock's historical performance indicate challenges ahead.